Optimal Treatment for Patients With Progressive RCC After 1 or More Previous Lines of Therapy

Download these slides from a live webinar for the most recent data on the selection and sequencing of therapy for patients with advanced RCC after progression on first-line therapy.
Katy E. Beckermann, MD, PhD
Format: Microsoft PowerPoint (.ppt)
File Size: 4.86 MB
Released: June 5, 2022


Provided by the National Comprehensive Cancer Network in partnership with Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by educational grants from
AVEO Oncology
Eisai Inc.
Merck Sharp & Dohme Corp.
Pfizer, Inc.

Related Content

Expert faculty discuss key updates on treatment options in renal cell carcinoma, from Clinical Care Options (CCO)

Katy E. Beckermann, MD, PhD person default Naomi B. Haas, MD Eric Jonasch, MD Released: August 1, 2022

Downloadable clinical resource with practical guidance on how to talk with your transgender patients about gender identity, including related terminology, from Clinical Care Options (CCO)

Nelson F. Sanchez, MD
Program Director
Released: June 30, 2022

Commentary from Nelson F. Sanchez, MD, on caring for transgender individuals, from the healthcare disparities they face to how healthcare professionals can improve their care, from Clinical Care Options (CCO)

Nelson F. Sanchez, MD
Program Director
Released: June 28, 2022

Downloadable slideset from Eric Jonasch, MD on managing treatment-related adverse events for patients with RCC, from Clinical Care Options (CCO).

Eric Jonasch, MD Released: June 5, 2022

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.


Cookie Settings